These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 19059832)
61. In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro. Pasch MC; Timár KK; van Meurs M; Heydendael VM; Bos JD; Laman JD; Asghar SS J Pathol; 2004 Jul; 203(3):839-48. PubMed ID: 15221944 [TBL] [Abstract][Full Text] [Related]
62. FLICE-inhibitory protein: expression in early and late gestation human placentas. Ka H; Hunt JS Placenta; 2006; 27(6-7):626-34. PubMed ID: 16174530 [TBL] [Abstract][Full Text] [Related]
63. Alterations of glucosylceramide-beta-glucosidase levels in the skin of patients with psoriasis vulgaris. Alessandrini F; Pfister S; Kremmer E; Gerber JK; Ring J; Behrendt H J Invest Dermatol; 2004 Dec; 123(6):1030-6. PubMed ID: 15610510 [TBL] [Abstract][Full Text] [Related]
64. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Ichihara A; Jinnin M; Yamane K; Fujisawa A; Sakai K; Masuguchi S; Fukushima S; Maruo K; Ihn H Br J Dermatol; 2011 Nov; 165(5):1003-10. PubMed ID: 21711342 [TBL] [Abstract][Full Text] [Related]
65. A novel strategy for preventing human CD8+ cytotoxic T lymphocyte-mediated cytotoxicity against pig endothelial cells by overexpression of pig cellular FLICE-like inhibitory protein (c-FLIP) gene. Tanemura M; Saga A; Kawamoto K; Matsuda-Minehata F; Manabe N; Deguchi T; Nishida T; Sawa Y; Ito T Transplant Proc; 2006 Dec; 38(10):3315-7. PubMed ID: 17175259 [TBL] [Abstract][Full Text] [Related]
66. Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component. Lin YK; Leu YL; Yang SH; Chen HW; Wang CT; Pang JH J Dermatol Sci; 2009 Jun; 54(3):168-74. PubMed ID: 19303259 [TBL] [Abstract][Full Text] [Related]
67. Systemic treatment of psoriatic patients with bexarotene decreases epidermal proliferation and parameters for inflammation, and improves differentiation in lesional skin. Smit JV; de Jong EM; van Hooijdonk CA; Otero ME; Boezeman JB; van de Kerkhof PC J Am Acad Dermatol; 2004 Aug; 51(2):257-64. PubMed ID: 15280845 [TBL] [Abstract][Full Text] [Related]
68. Aberrant caveolin-1 expression in psoriasis: a signalling hypothesis. Campbell L; Gumbleton M IUBMB Life; 2000 Dec; 50(6):361-4. PubMed ID: 11327308 [TBL] [Abstract][Full Text] [Related]
69. Expression of p53 protein in psoriasis. Baran W; Szepietowski JC; Szybejko-Machaj G Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):79-83. PubMed ID: 16200332 [TBL] [Abstract][Full Text] [Related]
70. Effects of narrowband UV-B on pharmacodynamic markers of response to therapy: an immunohistochemical study over sequential samples. Carrascosa JM; Tapia G; Bielsa I; Fuente MJ; Ferrandiz C J Cutan Pathol; 2007 Oct; 34(10):769-76. PubMed ID: 17880582 [TBL] [Abstract][Full Text] [Related]
72. c-FLIPL expression defines two ovarian cancer patient subsets and is a prognostic factor of adverse outcome. Bagnoli M; Ambrogi F; Pilotti S; Alberti P; Ditto A; Barbareschi M; Galligioni E; Biganzoli E; Canevari S; Mezzanzanica D Endocr Relat Cancer; 2009 Jun; 16(2):443-53. PubMed ID: 19321593 [TBL] [Abstract][Full Text] [Related]
73. Study on the expression of RXRalpha in patients with psoriasis vulgaris. Feng S; Lin L; Wu Q; Zhou W; Shao C Eur J Dermatol; 2006; 16(1):33-8. PubMed ID: 16436339 [TBL] [Abstract][Full Text] [Related]
74. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes. van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439 [TBL] [Abstract][Full Text] [Related]
75. Influence of infliximab on keratinocyte apoptosis in psoriasis patients. Raho G; Vena GA; Bizzoca A; Cassano N; Garofalo E; Congedo M; Gennarini G Immunopharmacol Immunotoxicol; 2011 Mar; 33(1):227-31. PubMed ID: 20507213 [TBL] [Abstract][Full Text] [Related]
76. Expression of hurpin, a serine proteinase inhibitor, in normal and pathological skin: overexpression and redistribution in psoriasis and cutaneous carcinomas. Moussali H; Bylaite M; Welss T; Abts HF; Ruzicka T; Walz M Exp Dermatol; 2005 Jun; 14(6):420-8. PubMed ID: 15885077 [TBL] [Abstract][Full Text] [Related]
77. Pig cellular FLICE-like inhibitory protein (c-FLIP) overexpression in pig xenograft cells induces resistance to human CD8+ cytotoxic T lymphocyte-mediated xenocytotoxicity. Tanemura M; Saga A; Kawamoto K; Manabe N; Machida T; Deguchi T; Sawa Y; Nishida T; Ito T Transplant Proc; 2008 Mar; 40(2):559-63. PubMed ID: 18374129 [TBL] [Abstract][Full Text] [Related]
78. [Alteration of tazarotene induced gene-2 expression in psoriasis vulgaris]. Zheng Y; Luo SJ; Zeng WH; Peng ZH; Tan SS; Xi YP Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1792-4. PubMed ID: 18971174 [TBL] [Abstract][Full Text] [Related]
79. Immunohistochemical analysis of keratinocyte growth factor and fibroblast growth factor 10 expression in psoriasis. Kovacs D; Falchi M; Cardinali G; Raffa S; Carducci M; Cota C; Amantea A; Torrisi MR; Picardo M Exp Dermatol; 2005 Feb; 14(2):130-7. PubMed ID: 15679583 [TBL] [Abstract][Full Text] [Related]
80. Immunohistochemical analysis of Fas and FLIP in prostate cancers. Kim SY; Song SY; Kim MS; Lee JY; Lee HM; Choi HY; Yoo NJ; Lee SH APMIS; 2009 Jan; 117(1):28-33. PubMed ID: 19161534 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]